[62–64] Researchers have shown an improvement in ALT levels and other markers of lipid peroxidation with the use of probiotic VSL#3 in NAFLD patients ... Finally, several other drugs have ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

The first drug in the LAG-3 inhibitor class to reach the market was Bristol-Myers Squibb’s Opdualag, a fixed-dose combination of LAG-3 drug relatlimab with PD-1 inhibitor nivolumab, sold on its ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular therapy.

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront, plus as much as $2.7 billion in milestone payments. The deal with ...

Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication errors." The report showed the resident missed multiple doses of HIV ...

Low-extremity ischemic disease is a common complication in diabetic patients, leading to reduced quality of life and potential amputation. This study investigated the therapeutic effect of spinal cord ...

There were more grade 3/4 drug-related adverse events, however, coming in at 18.9% in the combination arm compared to 9.7% with Opdivo, and discontinuation rates were 14.6% and 6.7%, respectively.

While the flu shot is widely recommended, doctors are advising people to be careful about the medications they use before or after they get vaccinated because some drugs could decrease the vaccine ...

Best for chronic GI diseases Visbiome, formerly known as VSL#3, makes some of the most widely recommended probiotic supplements for both dogs and humans. It contains Bifidobacterium longum and ...